Sglt D 5mg Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Sglt D 5mg Tablet
Empagliflozin 5mg tablets are prescribed either independently or alongside other medications to manage type 2 diabetes. This medication effectively lowers elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to heart health preservation. Empagliflozin 5mg can be ingested with or without food, consistently at the same time daily, as determined by your physician. Discontinuation should only occur under medical supervision; otherwise, blood sugar levels may rise, potentially leading to serious consequences such as renal impairment and vision loss. This drug is a component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Common adverse effects include vaginal yeast infections, upper respiratory tract infections (nasopharyngitis), and urinary tract infections. It can induce excessive fluid loss, necessitating increased fluid intake to avoid dehydration. Practicing good hygiene minimizes the risk of genital fungal infections. Prior to commencing treatment, discuss any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating individuals require medical consultation before starting this medication. Limit alcohol consumption, as it might amplify side effects. Regular blood glucose monitoring is crucial during treatment.
Uses of Sglt D 5mg Tablet
Managing Type 2 Diabetes
Major Benefits of Sglt D 5mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. The 5mg Sglt D tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Sglt D 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Sglt D 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The 5mg Sglt D tablet can be administered with or without food, though consistent timing is recommended.
How Sglt D 5mg Tablet works:
Dapagliflozin 5mg tablets are used to manage type 2 diabetes. Their mechanism of action involves eliminating surplus glucose via urinary excretion.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Sglt D 5mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Sglt D 5mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Sglt D 5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyUNSAFE
Patients with kidney disease should likely avoid Sglt D 5mg Tablets due to potential safety concerns. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The 5mg Sglt D tablet presents no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Sglt D 5mg Tablet :
Should you forget to take your 5mg Sglt D Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Sglt D 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Behavioral Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently